China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.71 Million ≈ $18.54 Million USD) by net assets (CN¥37.38 Billion ≈ $5.47 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000999 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Resources Sanjiu Medical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mianyang Fulin Precision Machining Co Ltd
SHE:300432
|
0.033x |
|
Rising Nonferrous Metals Share Co Ltd
SHG:600259
|
0.179x |
|
Western Superconducting Tech Co Ltd
SHG:688122
|
-0.040x |
|
Thai Airways International Public Company Limited
BK:THAI
|
0.005x |
|
The People's Insurance Company (Group) of China Limited
F:PIR
|
0.071x |
|
RTL Group SA
XETRA:RRTL
|
0.009x |
|
MEG Energy Corp
TO:MEG
|
0.029x |
|
Hanwha
KO:000880
|
0.032x |
Annual Cash Flow Conversion Efficiency for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 000999 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥25.26 Billion ≈ $3.70 Billion |
CN¥4.40 Billion ≈ $644.18 Million |
0.174x | +0.20% |
| 2023-12-31 | CN¥24.26 Billion ≈ $3.55 Billion |
CN¥4.22 Billion ≈ $617.58 Million |
0.174x | +1.45% |
| 2022-12-31 | CN¥17.53 Billion ≈ $2.57 Billion |
CN¥3.01 Billion ≈ $439.93 Million |
0.171x | +44.03% |
| 2021-12-31 | CN¥15.71 Billion ≈ $2.30 Billion |
CN¥1.87 Billion ≈ $273.72 Million |
0.119x | -24.75% |
| 2020-12-31 | CN¥14.06 Billion ≈ $2.06 Billion |
CN¥2.22 Billion ≈ $325.44 Million |
0.158x | +3.34% |
| 2019-12-31 | CN¥12.88 Billion ≈ $1.89 Billion |
CN¥1.97 Billion ≈ $288.54 Million |
0.153x | -10.55% |
| 2018-12-31 | CN¥11.17 Billion ≈ $1.63 Billion |
CN¥1.91 Billion ≈ $279.68 Million |
0.171x | +11.04% |
| 2017-12-31 | CN¥10.12 Billion ≈ $1.48 Billion |
CN¥1.56 Billion ≈ $228.33 Million |
0.154x | -3.45% |
| 2016-12-31 | CN¥8.72 Billion ≈ $1.28 Billion |
CN¥1.39 Billion ≈ $203.71 Million |
0.160x | -2.77% |
| 2015-12-31 | CN¥7.67 Billion ≈ $1.12 Billion |
CN¥1.26 Billion ≈ $184.35 Million |
0.164x | -3.04% |
| 2014-12-31 | CN¥7.00 Billion ≈ $1.02 Billion |
CN¥1.18 Billion ≈ $173.32 Million |
0.169x | -26.61% |
| 2013-12-31 | CN¥6.36 Billion ≈ $930.82 Million |
CN¥1.47 Billion ≈ $214.73 Million |
0.231x | +6.15% |
| 2012-12-31 | CN¥5.58 Billion ≈ $815.96 Million |
CN¥1.21 Billion ≈ $177.33 Million |
0.217x | +10.39% |
| 2011-12-31 | CN¥4.85 Billion ≈ $709.79 Million |
CN¥954.90 Million ≈ $139.73 Million |
0.197x | +3.59% |
| 2010-12-31 | CN¥4.46 Billion ≈ $653.19 Million |
CN¥848.28 Million ≈ $124.13 Million |
0.190x | -12.18% |
| 2009-12-31 | CN¥3.95 Billion ≈ $578.22 Million |
CN¥855.05 Million ≈ $125.12 Million |
0.216x | -33.85% |
| 2008-12-31 | CN¥3.41 Billion ≈ $499.38 Million |
CN¥1.12 Billion ≈ $163.36 Million |
0.327x | +55.83% |
| 2007-12-31 | CN¥2.88 Billion ≈ $421.94 Million |
CN¥605.30 Million ≈ $88.57 Million |
0.210x | +25.56% |
| 2006-12-31 | CN¥2.55 Billion ≈ $372.44 Million |
CN¥425.51 Million ≈ $62.26 Million |
0.167x | +1652.24% |
| 2005-12-31 | CN¥2.39 Billion ≈ $350.07 Million |
CN¥22.83 Million ≈ $3.34 Million |
0.010x | +103.03% |
| 2004-12-31 | CN¥2.29 Billion ≈ $334.78 Million |
CN¥-719.63 Million ≈ $-105.30 Million |
-0.315x | -3563.86% |
| 2003-12-31 | CN¥3.09 Billion ≈ $452.72 Million |
CN¥28.09 Million ≈ $4.11 Million |
0.009x | -94.69% |
| 2002-12-31 | CN¥2.90 Billion ≈ $424.65 Million |
CN¥496.12 Million ≈ $72.60 Million |
0.171x | +228.94% |
| 2001-12-31 | CN¥2.95 Billion ≈ $432.00 Million |
CN¥153.44 Million ≈ $22.45 Million |
0.052x | -41.96% |
| 2000-12-31 | CN¥2.98 Billion ≈ $436.10 Million |
CN¥266.86 Million ≈ $39.05 Million |
0.090x | +96.98% |
| 1999-12-31 | CN¥2.65 Billion ≈ $388.31 Million |
CN¥120.63 Million ≈ $17.65 Million |
0.045x | -- |
About China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products,… Read more